EPCAM and hepatocellular carcinoma: Four out of the six HCC patients had potential CTCs on IFC, as defined by a combination of factors: CD45 negative, at least 1 positive marker among pan-CK, GPC3, ASGPR1, or EPCAM, and compatible shape by bright field morphologic analysis.